Healthy participants
Conditions
Interventions
[1] Designated food intake (number of intakes: 8 times) [2] Animal Urine Measurement [3] Ingestion of test food B (number of intakes: 1 time) [4] Washout (2 weeks) [5] Designated food intake (numb
Sponsors
DRC Co., Ltd
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: [1] Healthy Glico Group Employees [2] Those with high fasting blood glucose levels (110~125mg/dL will be prioritized for screening tests) [3] Those who have voluntarily agreed to participate in the trial in writing
Exclusion criteria
Exclusion criteria: [1] Those with a fasting blood glucose level of 126 mg/dL or higher at the time of screening test [2] Those who are continuously consuming health foods, quasi-drugs, or pharmaceuticals that advocate or cooperate with the same or related effects as those examined in this study [3] Those who have started using health foods within the past 4 weeks [4] Those who work night shifts and day and night shifts [5] A person who is undergoing treatment (hormone replacement therapy, drug therapy, exercise therapy, diet, etc.) at a medical institution for the treatment or prevention of a disease at the time of obtaining consent, or a person who is judged to be in need of treatment [6] Those who have a history of glucose metabolism, lipid metabolism, liver function, kidney function, heart, circulatory system, respiratory system, endocrine system, immune system, nervous system, or psychiatric disorder [7] Those who have a history of alcohol or drug dependence [8] Those who are at risk of developing allergies to foods, especially those who are at risk of developing allergies to the ginger family [9] Those who have experienced poor mood or deterioration of physical condition due to blood collection in the past, or those who have been told that it is difficult to collect blood due to thin blood vessels [10] Those who regularly use supplements or pharmaceuticals, or those who are unable to refrain from using them [11] Persons with severe anemia symptoms [12] Those who are pregnant or breastfeeding at the time of obtaining consent, or who wish to become pregnant during the study period [13] Those who plan to participate in other human studies (e.g., human trials using foods, pharmaceuticals, quasi-drugs, medical devices, etc.) during the scheduled period of this study [14] A person who is judged by the study investigator or the study principal to be unfit to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary glucose | — |
Secondary
| Measure | Time frame |
|---|---|
| Urinary sodium, urinary uric acid | — |
Countries
Japan
Contacts
Public ContactKazumi Naganuma
DRC Co., Ltd Product Testing Department
Outcome results
None listed